|
Volumn 14, Issue 2, 1999, Pages 184-195
|
Clinical effectiveness, policies, and practices for influenza and pneumococcal vaccines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INFLUENZA VACCINE;
PNEUMOCOCCUS VACCINE;
ACTIVE IMMUNIZATION;
CLINICAL PROTOCOL;
DRUG EFFICACY;
HEALTH CARE POLICY;
HIGH RISK POPULATION;
HUMAN;
IMMUNOGENICITY;
INFECTION PREVENTION;
INFLUENZA;
INFLUENZA VACCINATION;
PRIORITY JOURNAL;
REVIEW;
STREPTOCOCCUS INFECTION;
STREPTOCOCCUS PNEUMONIAE;
ADULT;
AGED;
BACTERIAL VACCINES;
COMMUNITY-ACQUIRED INFECTIONS;
FEMALE;
GREAT BRITAIN;
HUMANS;
IMMUNIZATION PROGRAMS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
MALE;
MIDDLE AGED;
PNEUMOCOCCAL VACCINES;
PNEUMONIA, PNEUMOCOCCAL;
PNEUMONIA, VIRAL;
RISK FACTORS;
STATE MEDICINE;
|
EID: 0033008648
PISSN: 08820546
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (26)
|
References (116)
|